(Total Views: 218)
Posted On: 06/01/2017 12:25:16 PM
Post# of 5411

$NPHC The company previously announced that they had been granted an Orphan Designation from the US-FDA (Food and Drug Administration) for the treatment of Pediatric Multiple Sclerosis with RPI-78M. The designation is designed to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
https://finance.yahoo.com/news/nutra-pharma-a...00318.html
https://finance.yahoo.com/news/nutra-pharma-a...00318.html


Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!